This site is for US residents only

An innovative approach to early signal finding

Call me back

For more information about Signature trials, enter your contact details and a representative will call you at your convenience.

*Required Information

*First Name
*Last Name
*Phone Number
*Zip Code
*Preferred time to call
*Time zone

Your email has been successfully sent

There was an error while sending your email

Contact a medical science liaison

Please enter your information below and a Novartis Medical Science Liaison will be in touch.

*Required Information

*First Name
*Last Name
*Phone Number
*Zip Code
Speciality

Your email has been successfully sent

There was an error while sending your email

Signature is a modular Phase II trial to link targeted therapy to patients with pathway-activated tumors

  • Rapidly matches patients to therapies that target their tumors' genetic alterations
  • Features a rapid trial deployment model and patient-sparing adaptive statistical design